Novel AAV variants with improved tropism for human Schwann cells

Novel AAV variants with improved tropism for human Schwann cells

Gene therapies and associated technologies are transforming biomedical research and enabling novel therapeutic options for patients living with debilitating and incurable genetic disorders. The vector system based on recombinant adeno-associated viral vectors (AAVs) has shown great promise in recent...

Full description

Bibliographic Details
Main Authors:	Matthieu Drouyer, Tak-Ho Chu, Elodie Labit, Florencia Haase, Renina Gale Navarro, Deborah Nazareth, Nicole Rosin, Jessica Merjane, Suzanne Scott, Marti Cabanes-Creus, Adrian Westhaus, Erhua Zhu, Rajiv Midha, Ian E. Alexander, Jeff Biernaskie, Samantha L. Ginn, Leszek Lisowski
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Molecular Therapy: Methods & Clinical Development
Subjects:	AAV adeno-associated vector Schwann cells gene therapy vector engineering directed evolution
Online Access:	http://www.sciencedirect.com/science/article/pii/S2329050124000500

Similar Items

Single amino acid insertion allows functional transduction of murine hepatocytes with human liver tropic AAV capsids
by: Marti Cabanes-Creus, et al.
Published: (2021-06-01)

A self-complementary AAV proviral plasmid that reduces cross-packaging and ITR promoter activity in AAV vector preparations
by: Noah K. Taylor, et al.
Published: (2024-09-01)

AAV vectors accumulate in the pineal gland after injections into the brain or spinal cord
by: Oswald Steward, et al.
Published: (2021-12-01)

AAVolve: Concatenated long-read deep sequencing enables whole capsid tracking during shuffled AAV library selection
by: Suzanne Scott, et al.
Published: (2024-12-01)

Identification of a novel neutralization epitope in rhesus AAVs
by: Gabriel Dagotto, et al.
Published: (2024-12-01)

Planet of the AAVs: The Spinal Cord Injury Episode
by: Katerina Stepankova, et al.
Published: (2021-05-01)

Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno‐Associated Viral Vector rAAV9P1
by: Amelie Bauer, et al.
Published: (2022-05-01)

Probing aspects of extracellular vesicle associated AAV allows increased vector yield and insight into its transduction and immune-evasive properties
by: Ming Cheng, et al.
Published: (2025-03-01)

The intersection of vector biology, gene therapy, and hemophilia
by: Leszek Lisowski, et al.
Published: (2021-08-01)

A novel class of self-complementary AAV vectors with multiple advantages based on cceAAV lacking mutant ITR
by: Junping Zhang, et al.
Published: (2024-03-01)

AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challenge
by: Laura P. van Lieshout, et al.
Published: (2022-09-01)

αFAP-specific nanobodies mediate a highly precise retargeting of modified AAV2 capsids thereby enabling specific transduction of tumor tissues
by: Olaniyi Olarewaju, et al.
Published: (2024-12-01)

Predictive power of deleterious single amino acid changes to infer on AAV2 and AAV2-13 capsids fitness
by: Tiziana La Bella, et al.
Published: (2024-09-01)

AAV8 gene therapy reverses cardiac pathology and prevents early mortality in a mouse model of Friedreich’s ataxia
by: Joshua C. Chang, et al.
Published: (2024-03-01)

Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal Models
by: Amira D. Rghei, et al.
Published: (2021-09-01)

Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistribution
by: Marti Cabanes-Creus, et al.
Published: (2023-03-01)

Transcriptional Targeting Approaches in Cardiac Gene Transfer Using AAV Vectors
by: Lena C. Schröder, et al.
Published: (2023-10-01)

Systemic delivery of AAV-GCDH ameliorates HLD-induced phenotype in a glutaric aciduria type I mouse model
by: Anna Mateu-Bosch, et al.
Published: (2024-09-01)

Gene therapy and peripheral nerve repair: a perspective
by: Stefan A. Hoyng, et al.
Published: (2015-07-01)

Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting
by: Livia S. Carvalho, et al.
Published: (2017-09-01)

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
by: Hironori Okada, et al.
Published: (2013-01-01)

Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector
by: Lars Maurer, et al.
Published: (2022-01-01)

Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue
by: Anca Remes, et al.
Published: (2021-06-01)

JSRV Intragenic Enhancer Element Increases Expression from a Heterologous Promoter and Promotes High Level AAV-Mediated Transgene Expression in the Lung and Liver of Mice
by: Darrick L. Yu, et al.
Published: (2020-11-01)

A blood-brain barrier-penetrant AAV gene therapy improves neurological function in symptomatic mucolipidosis IV mice
by: Madison L. Sangster, et al.
Published: (2024-06-01)

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method
by: Renuka Rao, et al.
Published: (2022-07-01)

A comprehensive study of AAV tropism across C57BL/6 mice, BALB/c mice, and crab-eating macaques
by: Kailun Fang, et al.
Published: (2025-03-01)

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
by: Artem A. Derkaev, et al.
Published: (2022-09-01)

AAV vectors for FRET-based analysis of protein-protein interactions in photoreceptor outer segments
by: Elvir Becirovic, et al.
Published: (2016-07-01)

Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality?
by: Qimeng Gao, et al.
Published: (2022-07-01)

Preclinical Assessment of Immune Responses to AAV (adeno-associated virus) Vectors
by: Etiena eBasner-Tschakarjan, et al.
Published: (2014-02-01)

Innate immune responses to AAV vectors
by: Geoffrey L Rogers, et al.
Published: (2011-09-01)

A role for adeno-associated viral vectors in gene therapy
by: Renata dos Santos Coura, et al.
Published: (2008-01-01)

Thorough molecular configuration analysis of noncanonical AAV genomes in AAV vector preparations
by: Junping Zhang, et al.
Published: (2024-03-01)

AAV-CRB2 protects against vision loss in an inducible CRB1 retinitis pigmentosa mouse model
by: Thilo M. Buck, et al.
Published: (2021-03-01)

Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment
by: J. Fraser Wright
Published: (2014-03-01)

<i>In vivo</i> evaluation of tropism and biodistribution of synthetic and natural adeno-associated viral vectors by next-generation sequencing
by: D. O. Maksimov, et al.
Published: (2024-07-01)

Identification of the role of SNARE proteins in rAAV vector production through interaction with the viral MAAP
by: Cagla Aksu Kuz, et al.
Published: (2025-03-01)

Recent Advancements in AAV-Vectored Immunoprophylaxis in the Nonhuman Primate Model
by: Elena S. B. Campbell, et al.
Published: (2023-08-01)

Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry
by: Edward E. Large, et al.
Published: (2021-07-01)